MedPath

Oregon Health and Science University

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Comparison of Doubled Quadrupled Versus Quadrupled Allograft Tissue Constructs for Anterior Cruciate Ligament (ACL) Reconstruction

Not Applicable
Completed
Conditions
Injury
Anterior Cruciate Ligament
Interventions
Procedure: ACL reconstruction
First Posted Date
2010-06-22
Last Posted Date
2019-07-11
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
102
Registration Number
NCT01148784
Locations
🇺🇸

Oregon Health & Science University, Portland, Oregon, United States

Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas

Early Phase 1
Terminated
Conditions
Hemangioma
Infant
Interventions
Drug: topical 0.5% Timolol
Drug: Control (placebo) group
First Posted Date
2010-06-22
Last Posted Date
2017-07-05
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
6
Registration Number
NCT01147601
Locations
🇺🇸

Oregon Health & Science University, Portland, Oregon, United States

Feasibility Study of Barrier Enhancement for Eczema Prevention

Not Applicable
Conditions
Eczema
Interventions
Drug: Control group
Drug: Sunflower oil
Drug: Aquaphor ointment
Drug: Cetaphil cream
First Posted Date
2010-06-14
Last Posted Date
2011-08-05
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
46
Registration Number
NCT01142999
Locations
🇺🇸

Oregon Health & Science University, Portland, Oregon, United States

Group Eczema Education Visits:Impact on Patient and Family Quality of Life

Not Applicable
Completed
Conditions
Eczema
Interventions
Other: Group eczema education session
Other: Control group
First Posted Date
2010-06-14
Last Posted Date
2019-07-11
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
36
Registration Number
NCT01143012
Locations
🇺🇸

Oregon Health & Science University, Portland, Oregon, United States

The Effect of a Non-hormonal Cox-2 Inhibitor (Celebrex) on Ovulation

Not Applicable
Completed
Conditions
Luteal Development
Ovulation
Interventions
Drug: Celebrex
Drug: Placebo
First Posted Date
2010-05-24
Last Posted Date
2019-06-18
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
20
Registration Number
NCT01129245
Locations
🇺🇸

Oregon Health & Science University, Portland, Oregon, United States

Examining Bladder Control Using Magnetic Resonance Imaging (MRI) and Diffusion Tensor Imaging (DTI)

Completed
Conditions
Urinary Incontinence, Urge
First Posted Date
2010-04-26
Last Posted Date
2017-08-22
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
47
Registration Number
NCT01110278
Locations
🇺🇸

Oregon Health & Science University, Portland, Oregon, United States

Effect of Continuous Positive Airway Pressure (CPAP) on Lower Esophageal Sphincter Pressure in Morbidly Obese Patients

Completed
Conditions
Gastroesophageal Reflux Disease
Sleep Apnea
First Posted Date
2010-04-07
Last Posted Date
2019-08-30
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
20
Registration Number
NCT01099735
Locations
🇺🇸

Oregon Health & Science University, Portland, Oregon, United States

Telepsychiatry in Rural Youth

Not Applicable
Withdrawn
Conditions
Attention Deficit Hyperactivity Disorder
Interventions
Behavioral: Mental health care implemented by telepsychiatry
Behavioral: Face-to-face care
First Posted Date
2010-03-31
Last Posted Date
2019-09-11
Lead Sponsor
Oregon Health and Science University
Registration Number
NCT01096953
Locations
🇺🇸

Douglas County Health & Social Services, Roseburg, Oregon, United States

Paracervical Block for Pain Control in First Trimester Abortion

Phase 4
Completed
Conditions
Legal Abortion With Complication
Pain
Interventions
Procedure: Sham Paracervical Block
Procedure: Paracervical Block
First Posted Date
2010-03-26
Last Posted Date
2019-12-27
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
121
Registration Number
NCT01094366
Locations
🇺🇸

Planned Parenthood Columbia Willamette, Portland, Oregon, United States

Efficacy of Tart Cherry Juice to Reduce Pain and Inflammation Among Patients With Inflammatory Osteoarthritis

Phase 4
Completed
Conditions
Pain
Inflammation
Interventions
Dietary Supplement: tart cultivar Montmorency cherry juice
First Posted Date
2010-02-24
Last Posted Date
2011-01-20
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
20
Registration Number
NCT01073982
Locations
🇺🇸

Oregon Health and Science University, Portland, Oregon, United States

© Copyright 2025. All Rights Reserved by MedPath